GSK's Belantamab Among Drugs Seeking EU Approval Nod

Second Time Around For GSK's BCMA-Targeting Therapy

 
• By Neena Brizmohun

GlaxoSmithKline's potential multiple myeloma treatment is one of several new products that could get an EU marketing thumbs up from the European Medicines Agency this week.

Question Mark
Companies will find out this week whether their new drugs are likely to be approved across the EU • Source: Shutterstock

More from Product Reviews

More from Pink Sheet